1. Home
  2. MERC vs TMCI Comparison

MERC vs TMCI Comparison

Compare MERC & TMCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mercer International Inc.

MERC

Mercer International Inc.

HOLD

Current Price

$1.12

Market Cap

106.5M

ML Signal

HOLD

Logo Treace Medical Concepts Inc.

TMCI

Treace Medical Concepts Inc.

HOLD

Current Price

$1.81

Market Cap

120.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MERC
TMCI
Founded
1968
2014
Country
Canada
United States
Employees
N/A
N/A
Industry
Paper
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
106.5M
120.4M
IPO Year
2005
2021

Fundamental Metrics

Financial Performance
Metric
MERC
TMCI
Price
$1.12
$1.81
Analyst Decision
Hold
Hold
Analyst Count
3
6
Target Price
$2.50
$4.77
AVG Volume (30 Days)
382.1K
432.4K
Earning Date
04-30-2026
05-07-2026
Dividend Yield
5.77%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,169,145,000.00
$212,690,000.00
Revenue This Year
$13.75
N/A
Revenue Next Year
$10.12
$8.17
P/E Ratio
N/A
N/A
Revenue Growth
25.50
1.59
52 Week Low
$1.23
$1.17
52 Week High
$5.31
$7.78

Technical Indicators

Market Signals
Indicator
MERC
TMCI
Relative Strength Index (RSI) 28.68 63.42
Support Level N/A $1.24
Resistance Level $1.46 $2.20
Average True Range (ATR) 0.10 0.15
MACD 0.01 0.07
Stochastic Oscillator 1.47 62.42

Price Performance

Historical Comparison
MERC
TMCI

About MERC Mercer International Inc.

Mercer International Inc is a forest products company with two reportable operating segments in pulp and solid wood. The pulp segment consists of the manufacture, sale, and distribution of pulp, electricity, and chemicals. The company has a geographical presence in the USA, Germany, China, and Other countries, where the majority of revenue is generated from the USA. The majority of the revenue is generated from the Pulp segment.

About TMCI Treace Medical Concepts Inc.

Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.

Share on Social Networks: